https://www.healthday.com/healthpro-news/neurology/fda-approves-subcutaneous-leqembi-for-treatment-of-early-alzheimer-disease
The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous...
alzheimer diseasefdagreenlightssubcutaneousleqembi
https://www.womansworld.com/aging/alzheimers/leqembi-faq
Jan 26, 2023 - The new Alzheimer's drug, Leqembi, was recently approved by the FDA. What are the pros and cons? Get all your questions answered here.
the newfaqalzheimerdrugleqembi